■ Healthcare & Earnings Highlights
Pfizer (PFE)
Phase 2 Success: Pfizer announced that its experimental obesity drug 'PF-3944' demonstrated significant weight loss—up to 12.3% compared to the placebo group over 28 weeks.
Competitive Edge: Unlike weekly injections from Eli Lilly (LLY) and Novo Nordisk (NVO), PF-3944 is designed for once-a-month administration, offering a major convenience advantage.
Earnings Beat: Reported Q4 adjusted EPS of $0.66 (vs. $0.58 est) on revenue of $17.58B (vs. $16.91B est).
PepsiCo (PEP)
Solid Beat: Reported Q4 adjusted EPS of $2.26 (vs. $2.24 est) and revenue of $29.34B (vs. $28.97B est).
Organic Growth: Revenue rose 5.6% YoY, with organic revenue up 2.1%. Management reaffirmed its FY2026 guidance.
Merck (MRK)
Mixed Results: Q4 adjusted EPS ($2.04) met estimates, and revenue ($16.4B) slightly beat the $16.18B forecast.
Weak Guidance: 2026 EPS guidance of $5.00–$5.15 fell short of the $5.63 consensus due to one-time costs (~$3.65/share) from the Cidara Therapeutics acquisition.
■ AI, Cloud & Semiconductor Strategy
Microsoft (MSFT) & Nvidia (NVDA)
Top AI Picks: Wall Street ranks Microsoft as the #1 AI leader (PT $602.51) due to Azure performance and the OpenAI partnership. Nvidia follows at #2 with a $253.62 average PT, suggesting 45.7% upside.
Snowflake (SNOW)
OpenAI Partnership: Snowflake's deal allows 12,600 customers to access OpenAI models directly via Cortex AI.
Analyst Views: Raymond James noted Snowflake’s AI portfolio generates $100M in ARR. RBC Capital maintained a Buy ($300 PT), citing its core role in data warehousing.
Teradyne (TER)
Initiated at Buy: Aletheia Capital set a $400 target, projecting net income to triple by 2027.
Chiplet Demand: Testing demand is surging for advanced architectures like Nvidia’s Rubin Ultra, Apple’s A20 SoC, and Alphabet’s Axion CPU.
■ Industrials, Logistics & Consumer Services
FedEx (FDX)
Massive Upgrades: Bernstein raised its target to $427 (Outperform), and Wells Fargo hiked to $380 (Overweight).
Catalysts: Analysts view the potential spin-off of the Freight unit and a 200bp margin improvement in Express as game-changers. The path to $30 EPS by FY2029 is seen as increasingly visible.
Caterpillar (CAT)
Target Hike: Truist raised its PT to $786 (Buy) on high-quality Q4 earnings. DA Davidson raised its target to $650, citing strong data center construction demand, though warning of tariff-related margin pressure.
Woodward (WWD)
Surprise Beat: Reported Q1 EPS of $2.17 (vs. $1.65 est) and revenue of $996M (vs. $893M est), with a robust 20.9% EBITDA margin.
Palantir (PLTR)
Beat Consensus: Reported results that exceeded market expectations.
■ Fintech & Real Estate Outlook
SoFi Technologies (SOFI)
Upgrade to Overweight: JPMorgan set a $31 target, calling SoFi the future "American Express of Fintech" due to record member and deposit growth compared to stagnating peers.
PayPal (PYPL)
Earnings Miss: Q4 revenue ($8.68B) and adjusted EPS ($1.23) both missed estimates.
Leadership Change: Announced Enrique Lores as the new CEO, effective March 1.
Rocket Companies (RKT)
Mortgage Recovery: CEO expects the highest volume in 4 years as 30-day mortgage rates hit 5.99%, the lowest since early 2023.
MicroStrategy (MSTR)
BTC Impact: Shares fell as Bitcoin prices dropped to the mid-$70,000 range.
